FYERS
Home
/
Stocks
/
Profit Loss
/
Syncom Formulations (India) Profit & Loss

Syncom Formulations (India) Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Dec 2013Mar 2013Dec 2012Mar 2012
₹126 Cr₹135 Cr₹115 Cr₹122 Cr₹117 Cr₹149 Cr₹128 Cr₹102 Cr₹87 Cr₹75 Cr₹65 Cr₹64 Cr₹60 Cr₹61 Cr₹57 Cr₹54 Cr₹51 Cr₹58 Cr₹57 Cr₹53 Cr₹41 Cr₹35 Cr₹34 Cr₹27 Cr
₹8 Cr₹15 Cr₹6 Cr₹5 Cr₹6 Cr₹7 Cr₹4 Cr₹4 Cr₹1 Cr₹3 Cr₹5 Cr₹4 Cr₹2 Cr₹7 Cr₹2 Cr₹3 Cr₹3 Cr₹6 Cr₹2 Cr₹3 Cr₹25 L₹49 L₹40 L₹53 L
₹133 Cr₹150 Cr₹121 Cr₹127 Cr₹123 Cr₹156 Cr₹132 Cr₹106 Cr₹89 Cr₹78 Cr₹70 Cr₹68 Cr₹62 Cr₹68 Cr₹59 Cr₹57 Cr₹54 Cr₹64 Cr₹59 Cr₹56 Cr₹41 Cr₹35 Cr₹35 Cr₹27 Cr
₹101 Cr₹116 Cr₹95 Cr₹105 Cr₹102 Cr₹132 Cr₹114 Cr₹91 Cr₹78 Cr₹66 Cr₹59 Cr₹58 Cr₹54 Cr₹56 Cr₹53 Cr₹51 Cr₹49 Cr₹57 Cr₹53 Cr₹48 Cr₹37 Cr₹33 Cr₹31 Cr₹27 Cr
₹34 Cr₹37 Cr₹27 Cr₹24 Cr₹22 Cr₹25 Cr₹19 Cr₹16 Cr₹12 Cr₹13 Cr₹12 Cr₹10 Cr₹8 Cr₹13 Cr₹8 Cr₹7 Cr₹6 Cr₹8 Cr₹7 Cr₹8 Cr₹5 Cr₹3 Cr₹4 Cr₹1 Cr
₹25 L₹38 L₹26 L₹27 L₹25 L₹12 L₹20 L₹16 L₹39 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹72 L₹62 L₹50 L₹1 Cr₹15 L₹12 L₹2 L₹9 L₹11 L₹15 L
₹32 Cr₹34 Cr₹25 Cr₹22 Cr₹20 Cr₹23 Cr₹17 Cr₹15 Cr₹10 Cr₹10 Cr₹9 Cr₹8 Cr₹6 Cr₹10 Cr₹6 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹7 Cr₹4 Cr₹2 Cr₹3 Cr₹20 L
₹25 Cr₹25 Cr₹19 Cr₹17 Cr₹16 Cr₹18 Cr₹13 Cr₹11 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr₹4 Cr₹8 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹6 Cr₹3 Cr₹1 Cr₹2 Cr-₹85 L

Share Price Live Stats

Open (₹)22.45
Volume (₹)79.24 L
High (₹)22.45
Upper Circuit26.94
Low (₹)21.25
Lower Circuit17.96
Prev Close22.45
52W High (₹)27.49
Price21.56
52W Low (₹)10.21

Share Market Cap & Key Ratios Overview

M.Cap (₹)2112.18 Cr
Div. Yield (%)0.45
PE Ratio24.70
Debt to Equity0.00
Price to Book2.33
Book Value4.41
EPS (TTM)0.91
Face Value1.00
ROE (%)20.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SYNCOMFNSE
LTP
1W Low
1W High
Market cap (₹)
1764+4 (0.23%)
1725.50
1778
4,19,620Cr
9030-310 (-3.32%)
8937.50
9431.50
2,39,714Cr
4584.1-72.8 (-1.56%)
4551.80
4682
1,74,741Cr
1140.2+22.7 (2.03%)
1107.30
1150.90
1,12,119Cr
2018.5-18.1 (-0.89%)
2007.80
2069.20
1,10,008Cr
1328+27 (2.08%)
1300.20
1336.40
1,06,061Cr
1218.8+21.8 (1.82%)
1196.90
1250.70
1,01,339Cr
2347.6-20.9 (-0.88%)
2317.50
2426.80
96,244Cr
1677.9-15.1 (-0.89%)
1647.10
1715
95,590Cr
1980.9+24.4 (1.25%)
1925.70
1990.90
89,391Cr
21.56-1.72 (-7.39%)
21.25
23.95
2,112Cr
Empty box

No content available